Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-01-29

Clinical Trial Update: A Randomized, Clinical Trial of Vitamin E and Memantine in Alzheimer's Disease [Phase 3]

View source ↗

Summary

Phase 3 randomized trial evaluated the combination of memantine and vitamin E for Alzheimer's disease. Results from the study have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Memantine (memantine)
  • Vitamin E (tocopherol)

Snippet

Sponsor: US Department of Veterans Affairs | Conditions: Alzheimer's Disease | Phase 3 | Status: COMPLETED | Results posted: 2014-01-29